DUBLIN–(Business WIRE)–The “World-wide Pharmacogenomics Sector 2021-2026” report has been included to ResearchAndMarkets.com’s supplying.
The world-wide current market for pharmacogenomics ought to increase from $7.7 billion in 2021 to $12.7 billion by 2026 with a compound annual advancement fee (CAGR) of 10.6% for the time period of 2021-2026.
Report Scope:
This report gives an up-to-date overview of pharmacogenomics, which include supplies, equipment, and methods, and identifies latest and emerging applications for pharmacogenomic products.
The report delineates the present market place standing for pharmacogenomics, defines trends, and offers growth forecasts for the upcoming five years. The pharmacogenomics current market is analyzed centered on the following segments: technological innovation, product or service sort, finish-consumer, software, and region. In addition, technological difficulties, which include important events and the most current developments, are discussed.
The evaluation of latest revenues for pharmacogenomics is followed by a in-depth presentation of current market development tendencies, centered on field advancement, technological developments, and regional trends.
Pharmacogenomics is a group of technologies concentrating on the application of genomic screening to figure out drug response. This rather new industry of life sciences, which brings together biology, pharmacology and drugs to produce new prescription drugs and optimize their dosage, is bringing various advantages in healthcare, together with personalised medicine, therapies with substantial specificity, treatments for exceptional and challenging-to-get rid of illnesses, and therapies with decreased side outcomes.
The report has discovered five key sectors in which pharmacogenomics finds present and probable programs: cardiovascular ailment neurological and psychiatric disorders oncology respiratory and inflammatory diseases and health administration and predictive medication.
This analyze supplies an updated evaluation of pharmacogenomic technologies, together with elements, products, procedures, and applications. It also offers a thorough market assessment for pharmacogenomics by phase (technological innovation, merchandise kind, conclusion-user, software, and location), describing complex facets and trends that will have an affect on future advancement of this sector.
Purposes for oncology currently account for the premier share of the industry. Within just this segment, pharmacogenomic products and solutions are remaining utilized primarily for the treatment of breast, lung and blood cancer.
The Report Includes:
- 60 facts tables and 19 supplemental tables
- An overview of the world wide sector for pharmacogenomics
- Estimation of the sector sizing and analyses of marketplace developments, with facts from 2019, 2020, estimates for 2021, and projections of compound once-a-year advancement premiums (CAGRs) by means of 2026
- Analysis of existing current market for pharmacogenomics by product or service class, product variety, software, and location and evaluation of marketplace growth trends
- Evaluation of the pharmacogenomics market, resolve of the speediest-expanding technologies and highlights of the present-day and potential current market tendencies and newest technological developments
- Description of the appropriate investigate and advancement activities alongside with traits in recently issued U.S. patents
- Identification of present and rising programs for pharmacogenomics, and facts of main pharmacogenomic items and technologies, and major attributes of these systems
- Description of commercially offered pharmacogenomic products, their production processes and associated issues
- Detailed profiles of key gamers in the field, together with Abbott Laboratories, GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Novartis, Oxford Nanopore Technologies (ONT) and Thermo Fisher Scientific (TFS)
Vital Topics Protected:
Chapter 1 Introduction
- Examine Aims and Targets
- Motives for Undertaking This Review
- Intended Viewers
- Scope of Report
- Methodology and Information Resources
- Market Breakdown
- Analyst’s Credentials
- Personalized Investigate
- Related Reports
Chapter 2 Summary and Highlights
Chapter 3 Marketplace and Technological innovation Qualifications
- Pharmacogenomics
- World-wide Marketplace for Therapeutic Solutions
- Milestones in the Historical past of Pharmacogenomics and Current Situations
- Current and Emerging Apps for Pharmacogenomics
- Cardiovascular Ailments
- Oncology
- Respiratory and Inflammatory Disorders
- Neurological and Psychiatric Diseases
- Health Management and Predictive Drugs
- Other folks
Chapter 4 Engineering
- Introduction
- Procedures, Approaches, and Resources for Pharmacogenomics
- Solitary Nucleotide Polymorphisms
- Biomedical Informatics
- Tests Systems
- Drug Types
- Most up-to-date Technological Developments, 2018 to Current
- Machine Finding out Algorithm for Pharmacogenomics
- Biological Markers for Most cancers Detection
- Pharmacogenomics Screening in Most cancers Remedy
- Computational Modeling of One-Nucleotide Polymorphisms
- Genetic Polymorphisms Associated with Psoriasis
- Method for Blocking Side Consequences with Immunotherapy
- Other Appropriate R&D Functions
Chapter 5 World Marketplaces
- Define of Evaluation
- Worldwide Industry Summary
- Existing Market Position
- Market by Engineering
- Industry by Merchandise Sort
- Market place by End Person
- Sector by Software
- Industry by Area
- Marketplace Expansion Tendencies
- Oncology
- Neurological and Psychiatric Conditions
- Respiratory and Inflammatory Conditions
- Cardiovascular Conditions
- Other Purposes
- Other Technological Tendencies
- Regional Trends
- Current market Forecast
- Industry by Technological innovation
- Market by Products Form
- Market by Conclusion Consumer
- Marketplace by Software
- Industry by Location
Chapter 6 Worldwide Industry Composition and Enterprise Profiles
- Major Suppliers of Pharmacogenomic Systems
- Distribution of Main Suppliers by Solution Style and Region
- Other Marketplace Gamers
- Enterprise Profiles
- Abbott Laboratories
- Agilent Technologies
- Bayer
- Becton, Dickinson and Co.
- Bio-Rad Laboratories
- Bristol Myers Squibb
- Diatech Pharmacogenomics
- Glaxosmithkline
- Illumina
- Johnson & Johnson
- Lgc Biosearch Systems
- Nanostring
- Novartis
- Oxford Nanopore Technologies
- Pacific Biosciences
- Pfizer
- Qiagen
- Roche
- Spartan Bioscience
- Thermo Fisher Scientific
Chapter 7 Patent Analysis
- Introduction
- Summary of Just lately Awarded Patents
- Typical Trends
- Developments by State and Region
- Trends by Assignee
- Developments by Patent Category
- Trends by Technological know-how Form
- Developments by Application
For much more facts about this report stop by https://www.researchandmarkets.com/r/uve9on
About the Author
